Crotalus Horridus Pellet
Product Images NDC 15631-0159

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Crotalus Horridus (NDC 15631-0159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0159

Label Pellets Fda 15631 0159
This is a description of a homeopathic medicine, specifically Crotalus Horridus 8X EikE, which contains sucrose as an inactive ingredient. The medicine is intended to provide temporary relief from discomfort caused by temporary light-sensitive conditions. The recommended dose is 4-6 pellets three times a day for adults, while for children who are two years and older, 12 pellets is recommended as equivalent to the adult dose. If one's symptoms do not improve in four days, or worsen, it is suggested to discontinue the use of this product and seek the assistance of a healthcare professional. The medicine should be kept in a cool and dark place, away from the reach of children. Manufacturing details and an NDC number are provided.*
FDA Label Image

Mini Labels Pellets Fda15631 0159

Mini Labels Pellets Fda15631 0159
CROTALUS HORRIDUS 8X is a homeopathic medicine used for temporary relief from discomfort due to temporary light. The ingredients include active and inactive ingredients, where the active ingredient is not disclosed. The medicine contains sucrose and comes in pellet form. The suggested dosage for adults is 4 pellets by mouth, three times daily or as directed by the physician, and for children above 2 years old, it is half the adult dose. The label includes a code, manufacturing date, expiry date, and other details. However, there is a note stating that the medicine's effectiveness is not supported by scientific evidence, and it is not FOA regulated.*
FDA Label Image

Rxhomeo Secondary Packing Blister Pack

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

Rxhomeo   Secondary Packing   Carton Pack
This is a description of a lactose-free single homeopathic remedy manufactured in India by Rihomeo Private Limited. It is made according to the Homoeopathic Pharmacopoeia of the United States (HPUS). The product comes with a warning that it should not be used for serious conditions and if symptoms do not improve after four days, it is best to discontinue use and contact a healthcare professional. The product is distributed by Rehomeo, Inc. based in Texas, USA. The text also includes notes related to packing and distribution.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.